Everolimus as adjunctive treatment in tuberous sclerosis complex-associated epilepsy in children.
CONCLUSIONS: Early data on everolimus as an adjunctive treatment in TSC-associated epilepsy are promising with regards to both effect and tolerability.
FUNDING: none.
TRIAL REGISTRATION: not relevant.
PMID: 31791480 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research
More News: Children | Denmark Health | Diets | Epilepsy | General Medicine | Nutrition | Pediatrics | Tuberous Sclerosis | Vagus Nerve Stimulation Therapy